In this case, a system known as CRISPR-Cas12 is used to recognize genetic signatures of the coronavirus that causes COVID-19 and then make cuts in it to release a fluorescent molecule that will ...

Mammoth Biosciences has secured an emergency authorization from the FDA for its high-throughput COVID-19 test, which is powered by CRISPR gene-editing enzymes. The company—born out of the work ...

Last month, the US Patent and Trademark Office reignited the infamous CRISPR patent dispute when it declared interference ... single-cell profiling to analyze immune memory to COVID-19 vaccines in ...

The CRISPR-based diagnostic test for COVID-19 may offer certain advantages over both serology (blood serum) and real-time reverse transcription-polymerase chain reaction (RT-PCR) tests ...

CRISPR-wielder Mammoth Biosciences will team up with Agilent Technologies to help launch its upcoming COVID-19 diagnostic test, designed to handle more than 4,000 samples per day. Applying the ...

We’ve featured other cutting edge stories on COVID-19 too; [Dan Maloney] took a look at how CRISPR techniques are helping with the testing effort. If there’s one thing the 2020 pandemic has ...

Just six years later, after earning a Nobel Prize, CRISPR began to make its way into over 20 clinical trials. The COVID-19 pandemic further demonstrated its potential, with CRISPR-based tests ...

The pandemic provided an opportunity for CRISPR to flex its muscles as a tool for potentially tracking and detecting new infectious disease culprits, as well as variants as COVID-19 continues to ...

The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...

The CRISPR-based diagnostic test for COVID-19 may offer certain advantages over both serology (blood serum) and real-time reverse transcription-polymerase chain reaction (RT-PCR) tests ...